Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,662 public trials 323 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients

NCT00406978

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Dip. Scienze Mediche & IRCAD-Università, UDA Ematologia Novara, Italy
  • Policlinico Monteluce, Clinica Medica I Perugia, Italy
  • Divisione Di Ematologia, Ospedali Riuniti Reggio Calabria, Italy
  • Servizio di Ematologia, Azienda Ospedaliera S. Maria Nuova Reggio Emilia, Italy
View Trial Details
Completed

MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma

NCT00833833

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View all 19 locations
View Trial Details
Completed

An Open-label, Dose-escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple Myeloma

NCT00552396

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Mont Sinai Medical Center New York, United States
  • Ohio State University Medical Center Columbus, Ohio, United States
  • Cancer Therapy Research Center at UTHSCSA San Antonio, Texas, United States
View Trial Details
Completed

Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma

NCT01359657

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • University Of Kansas Cancer Center And Medical Pavillion Westwood, Kansas, United States
  • Dana Faber Cancer Institute Boston, Massachusetts, United States
  • University Of Washington School Of Medicine Seattle, Washington, United States
View Trial Details

Related conditions